LATS2 (480-1088), GST étiqueté humain, recombinant, exprimé en cellules bactériulovirus infectées par Sf9, > = 70 % (SDS - PAGE), solution de glycérol aqueuse tamponnée

Code: srp5202-20ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

LATS2 is a serine/threonine protein kinase belonging to the LATS tumor suppressor family. The kinase activity and two conserved domains within LATS2 are r...


en savoir plus

Votre prix
$380.68 20UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

LATS2 is a serine/threonine protein kinase belonging to the LATS tumor suppressor family. The kinase activity and two conserved domains within LATS2 are responsible for the suppression of tumorigenicity and inhibition of cell growth. LATS2 negatively regulates the cell cycle by controlling G1/S and/or G2/M transition. LATS2 interacts with the centrosomal proteins AURORA A and Ajuba and is required for accumulation of γ-tubulin and spindle formation at the onset of mitosis. LATS2 also interacts with a negative regulator of p53 and may function in a positive feedback loop with p53 that responds to cytoskeleton damage. LATS2 can also function as a co-repressor of androgen-responsive gene expression.

Physical form

Supplied in 50mM Tris-HCl, pH 7.5, 150mM NaCl, 10mM glutathione, 0.1mM EDTA, 0.25mM DTT, 0.1mM PMSF, 25% glycerol.

Preparation Note

after opening, aliquot into smaller quantities and store at -70 °C. Avoid repeating handling and multiple freeze/thaw cycles

assay≥70% (SDS-PAGE)
formbuffered aqueous glycerol solution
Gene Informationhuman ... LATS2(26524)
mol wt~98 kDa
NCBI accession no.NM_014572
recombinantexpressed in baculovirus infected Sf9 cells
shipped indry ice
storage temp.−70°C
Ce produit répond aux critères suivants: